Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (8): 800-802.DOI: 10.3969/j.issn.1673-8640.2022.08.019
Previous Articles Next Articles
Received:2021-07-30
Revised:2021-09-15
Online:2022-08-30
Published:2022-09-16
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2022.08.019
| [1] |
FOGARTY H, DOHERTY D, O'DONNELL J S. New developments in von Willebrand disease[J]. Br J Haematol, 2020, 191(3):329-339.
DOI URL |
| [2] |
LEEBEEK F W, EIKENBOOM J C. Von Willebrand's disease[J]. N Engl J Med, 2016, 375(21):2067-2080.
DOI URL |
| [3] |
LAFFAN M A, LESTER W, O'DONNELL J S, et al. The diagnosis and management of von Willebrand disease:a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology[J]. Br J Haematol, 2014, 167(4):453-465.
DOI URL |
| [4] | 王兆钺. 血管性血友病诊治进展[J]. 中国实用内科杂志, 2008, 28(10):813-816. |
| [5] |
RODEGHIERO F, TOSETTO A, ABSHIRE T, et al. ISTH/SSC bleeding assessment tool:a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders[J]. J Thromb Haemost, 2010, 8(9):2063-2065.
DOI URL |
| [6] |
KRUSE-JARRES R, JOHNSEN J M. How I treat type 2B von Willebrand disease[J]. Blood, 2018, 131(12):1292-1300.
DOI URL |
| [7] | 薛峰, 杨仁池. ASH ISTH NHF WFH 2021血管性血友病诊断指南解读[J]. 中华血液学杂志, 2021, 42(5):358-363. |
| [8] |
SHARMA R, FLOOD V H. Advances in the diagnosis and treatment of von Willebrand disease[J]. Blood, 2017, 130(22):2386-2391.
DOI URL |
| [9] | 张威, 程大卫, 阮长耿. 血管性血友病因子的瑞斯托霉素辅因子定量测定[J]. 血栓与止血学杂志, 1994, 1(3):112-113. |
| [10] |
KITCHEN S, JENNINGS I, WOODS T A, et al. Laboratory tests for measurement of von Willebrand factor show poor agreement among different centers:results from the United Kingdom National External Quality Assessment Scheme for Blood Coagulation[J]. Semin Thromb Hemost, 2006, 32(5):492-498.
DOI URL |
| [11] |
SUCKER C, SENFT B, SCHARF R E, et al. Determination of von Willebrand factor activity:evaluation of the HaemosIL assay in comparison with established procedures[J]. Clin Appl Thromb Hemost, 2006, 12(3):305-310.
DOI URL |
| [12] |
DE VLEESCHAUWER A, DEVREESE K. Comparison of a new automated von Willebrand factor activity assay with an aggregation von Willebrand ristocetin cofactor activity assay for the diagnosis of von Willebrand disease[J]. Blood Coagul Fibrinolysis, 2006, 17(5):353-358.
DOI URL |
| [13] | SAGHEER S, RODGERS S, YACOUB O, et al. Comparison of von Willebrand factor(VWF)activity levels determined by HemosIL AcuStar assay and HemosIL LIA assay with ristocetin cofactor assay by aggregometry[J]. Haemophilia, 2016, 22(3):e200-e207. |
| [14] | 熊立凡, 姚依婷, 王鸿利. 解读血管性血友病的治疗指南[J]. 内科理论与实践, 2012, 7(1):51-55. |
| [1] | ZHOU Ying, REN Yihui, LI Guangming. Serum miR-148a expression in children with autoimmune hepatitis and its correlation with inflammatory factors [J]. Laboratory Medicine, 2023, 38(12): 1130-1134. |
| [2] | YAN An, GUAN Xuhuizi, YU Tian, MIAO Gang, ZHAO Yanyang. Identification of a new susceptibility gene variant EPB41L4A rs1455421289 in Chinese PTC patients by WES [J]. Laboratory Medicine, 2023, 38(11): 1009-1014. |
| [3] | GAO Jianchao, WANG Sisi, ZHANG Zhisheng, ZHANG Jingli, LI Xiaoxia, MA Ke, FENG Zhilin, ZHOU Haifeng, WANG Zhanhai. Efficacy and prognosis evaluation of neo-adjuvant chemotherapy for breast cancer based on miR-206，miR-125 and miR-21 [J]. Laboratory Medicine, 2023, 38(11): 1062-1068. |
| [4] | ZHU Qian, ZHU Lifang, MA Caiyun, YAO Jie. Relation of serum miR-140-5p and PGC-1α mRNA expression with vascular cognitive impairment in acute ischemic stroke patients [J]. Laboratory Medicine, 2023, 38(11): 1069-1074. |
| [5] | HUANG Zhongqiang, DAI Di, HOU Tieying, LIN Faquan, LU Zhiming, LIU Xiaoqi, SHEN Minna, WU Jie, ZHANG Pingan, ZHOU Jun, XIAO Yanqun, WANG Hualiang. Multicenter performance evaluation of a 7-microRNA test kit [J]. Laboratory Medicine, 2023, 38(11): 1075-1081. |
| [6] | XUE Yaze, HE Jin, TANG Shaojun. Roles of serum miR-150-5p and LTBP-2 determinations in evaluating the condition of acute cerebral infarction patients [J]. Laboratory Medicine, 2023, 38(11): 1082-1086. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(11): 1106-1108. |
| [8] | GUO Mingri, LI Yuming, LI Yan, SUN Haibai. Difference in identification of non-tuberculous Mycobacterium between microarray chip and multiple homologous sequence [J]. Laboratory Medicine, 2023, 38(10): 909-914. |
| [9] | ZHOU Jun, LI Liheng, ZHANG Min. Expressions of serum miR-24 and XIAP mRNA in serum of oral adenoid cystic carcinoma patients and relationship with prognosis [J]. Laboratory Medicine, 2023, 38(10): 930-935. |
| [10] | LI Liangshan, ZHAO Hu, WANG Shiwen. Screening potential prognostic biomarkers of colorectal cancer based on weighted gene co-expression network analysis [J]. Laboratory Medicine, 2023, 38(9): 825-832. |
| [11] | WANG Wei, ZHANG Zhixin, ZHANG Chuanbao, ZHOU Weiyan, WANG Zhiguo. Establishment of allowable total error，allowable imprecision and allowable bias for 22 endocrine analytes [J]. Laboratory Medicine, 2023, 38(8): 707-712. |
| [12] | Clinical Laboratory Society of Chinese Association for Rehabilitation Medicine , Molecular Diagnostics Society of Shanghai Medical Association , Tumor Immunology Branch of Shanghai Society for Immunology , Yueyang Hospital of Integrated Traditional Chinese and Western Medicine of Shanghai University of Traditional Chinese Medicine , Shanghai Center for Clinical Laboratory, Clinical Laboratory Society of Chinese Association of Integrative Medicine , Clinical Laboratory Society of Shanghai Anticancer Association , Tumor Markers Society of Shanghai Anticancer Association . Expert consensus on the clinical application of AFP，AFP-L3% and DCP using GALAD and GALAD-like models in hepatocellular carcinoma [J]. Laboratory Medicine, 2023, 38(7): 607-623. |
| [13] | ZHANG Xin, MA Lijuan. Role of cardiac markers in children [J]. Laboratory Medicine, 2023, 38(6): 505-509. |
| [14] | LIU Ruili, LI Lanjun, JIA Minlei, WANG Yihui, HAO Weina. Correlation between tumor miR-7-5p and NOVA2 levels and clinical prognosis in cancer tissues of patients with gastric cancer [J]. Laboratory Medicine, 2023, 38(4): 325-329. |
| [15] | WANG Xin, DENG Qian, WANG Juanjuan, CAI Wenjuan, GAO Jian, HAN Yanping, HU Kefei, CHEN Yuqing. Clinical characteristics and genetic analysis of Desbuquois dysplasia Kim type caused by CANT1 mutation [J]. Laboratory Medicine, 2023, 38(2): 130-136. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
